AMDI Unveils Revolutionary Autolab™ HBH System at ESCMID 2025 Conference

In a significant advancement for molecular diagnostics, Autonomous Medical Devices Incorporated (AMDI) has launched its latest innovation, the Autolab™ HBH, at the ESCMID Global Congress 2025 held in Vienna. This state-of-the-art sample preparation system marks a revolutionary step towards enhancing the efficiency and effectiveness of molecular workflows in laboratories.

The Autolab™ HBH system leverages AMDI's unique Hyperbaric Heating (HBH) technology. Traditional sample preparation methods often involve lengthy procedures, with extraction kits requiring up to 45 minutes and several manual steps. In stark contrast, the Autolab™ HBH completes sample processing in under two minutes, providing a swift and economically viable solution for laboratories. This innovation not only reduces processing time significantly but ensures a high yield of nucleic acids needed for various diagnostic applications.

David Okrongly, the CEO of AMDI, commented, “The Autolab™ HBH system was developed to tackle the persistent challenges faced during sample preparation—complexity, costs, and time. Our launch is a testament to our dedication to offering advanced tools that simplify and enhance molecular laboratory workflows, expanding access to high-quality molecular testing from PCR to sequencing.”

The versatility of the Autolab™ HBH system makes it useful across multiple sectors, including clinical research, public health, and environmental monitoring. Currently, it is designated for research use only (RUO) but demonstrates great promise for future applications in clinical standards.

At the ESCMID 2025 conference, live demonstrations of the Autolab™ HBH system are available, showcasing the system's capabilities at Booth #D760. Attendees have the opportunity to witness firsthand how this innovative technology can transform molecular diagnostics, ensuring labs can achieve faster results without compromising quality.

Autonomous Medical Devices Incorporated is headquartered in California, dedicated to developing next-generation diagnostic technology. Their products, which are designed and manufactured in an ISO 13485-certified facility in Santa Ana, California, aim to improve the speed, accessibility, and accuracy of molecular testing worldwide.

As the healthcare landscape continues to evolve, the introduction of the Autolab™ HBH marks a pivotal moment in the quest for efficient and effective diagnostic solutions. This technology not only promises to accelerate sample preparation but also to enhance the overall quality of diagnostic testing, empowering laboratories to deliver results that can significantly impact patient care.

For more information about AMDI and the Autolab™ HBH system, please visit their website or contact the media representative, Brian Miller, directly at [email protected].